Dane Andreeff - Nov 22, 2022 Form 4/A - Amendment Insider Report for HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT)

Signature
/s/ Dane Andreeff
Stock symbol
HSDT
Transactions as of
Nov 22, 2022
Transactions value $
$29,613
Form type
4/A - Amendment
Date filed
11/25/2022, 03:26 PM
Date Of Original Report
Nov 23, 2022
Previous filing
Nov 18, 2022
Next filing
Dec 19, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HSDT Common Stock Purchase $2.92K +10.3K +4.94% $0.28 219K Nov 22, 2022 See footnote F1, F2
transaction HSDT Common Stock Purchase $13.1K +42.2K +19.27% $0.31 261K Nov 23, 2022 See footnote F1, F2
transaction HSDT Common Stock Purchase $3.15K +10.1K +23.01% $0.31 54K Nov 23, 2022 See footnote F1, F3
transaction HSDT Common Stock Purchase $9.61K +30.8K +11.17% $0.31 307K Nov 23, 2022 See footnote F1, F4
transaction HSDT Common Stock Purchase $782 +2.51K +22.96% $0.31 13.4K Nov 23, 2022 See footnote F1, F5
holding HSDT Common Stock 1.51K Nov 22, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 4/A is being filed to amend an inadvertent error in the number of shares purchased by the Reporting Person in the Form 4 previously filed on November 23, 2022.
F2 The shares are held by Maple Leaf Partners, L.P. ("MLP"). The reporting person is the managing member of Maple Leaf Capital I, LLC ("Maple Leaf Capital"), the general partner of MLP and as such may be deemed to beneficially own the securities owned by MLP. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.
F3 The shares are held by Maple Leaf Partners I, L.P. ("MLP I"). The reporting person is the managing member of Maple Leaf Capital, the general partner of MLP I and as such may be deemed to beneficially own the securities owned by MLP I. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.
F4 The shares are held by Maple Leaf Discovery I, L.P. ("MLD I"). The reporting person is the managing member of Maple Leaf Capital, the general partner of MLD I and as such may be deemed to beneficially own the securities owned by MLD I. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.
F5 The shares are held by Maple Leaf Offshore Ltd. ("MLO"). The reporting person is the president of the managing member of Andreeff Equity Advisors, L.L.C., the investment manager of MLO and as such may be deemed to beneficially own the securities owned by MLO. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.